A 48-year-old man with 20 years of heavy alcohol use presents to the emergency department 36 hours after his last drink. He is tremulous, diaphoretic, and tachycardic (HR 110/min). He reports hearing voices accusing him of theft, but he knows these voices are not real. He is oriented to person, place, time, and situation. All of the following are appropriate management steps EXCEPT:

Explanation

## Management of Alcohol Withdrawal and Hallucinosis ### Clinical Context: Alcohol Hallucinosis **Key Point:** This patient presents with alcohol hallucinosis (auditory hallucinations in clear sensorium 12–48 hours post-cessation), not delirium tremens. Management differs significantly. ### Why Option 3 Is Incorrect **High-Yield:** Antipsychotics are **NOT** first-line for alcohol hallucinosis. Benzodiazepines are the cornerstone of withdrawal management and are often sufficient to resolve hallucinosis as withdrawal improves. **Clinical Pearl:** Antipsychotics may be considered **adjunctively** if hallucinations persist despite adequate benzodiazepine therapy, but they are never first-line. Moreover, haloperidol carries risk of QT prolongation and should be avoided in the setting of electrolyte disturbances (common in alcohol withdrawal). ### Correct Management Algorithm ```mermaid flowchart TD A[Alcohol withdrawal suspected]:::outcome --> B{Assess severity}:::decision B -->|Mild: tremor, anxiety| C[Benzodiazepine + supportive care]:::action B -->|Moderate: hallucinosis, autonomic hyperactivity| D[Benzodiazepine + thiamine + electrolyte correction]:::action B -->|Severe: seizures, DTs| E[Intensive benzodiazepine + ICU monitoring]:::action C --> F[Thiamine 100 mg daily]:::action D --> F E --> F F --> G[Correct Mg, K, Ca, PO4]:::action G --> H[Monitor for complications]:::action H --> I{Hallucinations persist?}:::decision I -->|Yes, after BZD optimization| J[Consider adjunctive antipsychotic]:::action I -->|No| K[Continue supportive care]:::action ``` ### Correct Management Elements | Component | Rationale | Details | |-----------|-----------|----------| | **Benzodiazepines** | First-line; reduce seizure risk, autonomic hyperactivity, and anxiety | Lorazepam or diazepam, titrated to clinical effect (CIWA-Ar scale) | | **Thiamine** | Prevent Wernicke encephalopathy (confusion, ataxia, ophthalmoplegia) | 100 mg IV/IM daily × 3–5 days; give **before** glucose | | **Electrolyte correction** | Hypomagnesemia, hypokalemia, hypophosphatemia impair cardiac function and increase seizure risk | Aggressive repletion required | | **Antipsychotics** | **Adjunctive only** if hallucinations persist despite benzodiazepine optimization | Not first-line; haloperidol risks QT prolongation | **Mnemonic:** **BATE** — **B**enzodiazepines, **A**ntiseptic (thiamine), **T**reatment of electrolytes, **E**valuation for complications. ### Why Antipsychotics Are Not First-Line 1. Benzodiazepines alone often resolve hallucinosis as withdrawal improves. 2. Antipsychotics do not prevent seizures or address autonomic hyperactivity. 3. Haloperidol is contraindicated in electrolyte disturbances (QT prolongation risk). 4. Antipsychotics may mask or delay recognition of delirium tremens if withdrawal progresses. [cite:Harrison 21e Ch 474; American Society of Addiction Medicine Clinical Practice Guideline]